Back to Search
ERIC NUERMBERGER, M.D.
M.D.
Infectious Disease Physician
NPI: 1477593150Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
D56070(MD)
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
D56070(MD)
Education
VANDERBILT UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
PMID 18285479·Antimicrob Agents Chemother·2008
7-preclinical
Using animal models to develop new treatments for tuberculosis.
PMID 18810687·Semin Respir Crit Care Med·2008
6-review
Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
PMID 17644711·J Med Microbiol·2007
7-preclinical
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
PMID 16870750·Antimicrob Agents Chemother·2006
4-observational
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
PMID 16151038·Am J Respir Crit Care Med·2005
4-observational
Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy.
PMID 16289711·Int J Antimicrob Agents·2005
7-preclinical
Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.
PMID 16305283·Pharmacotherapy·2005
6-review
Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.
PMID 14742554·Infect Immun·2004
7-preclinical
The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
PMID 14679455·Clin Infect Dis·2004
6-review
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.
PMID 15024625·Eur J Clin Microbiol Infect Dis·2004
4-observational
Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
PMID 15127371·Clin Infect Dis·2004
8-other
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.
PMID 15306535·Am J Respir Crit Care Med·2004
4-observational
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
PMID 14578218·Am J Respir Crit Care Med·2004
4-observational
Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
PMID 19075058·Antimicrob Agents Chemother·2009
7-preclinical
Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility.
PMID 19098156·Am J Respir Crit Care Med·2009
8-other
Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models.
PMID 19103767·Infect Immun·2009
7-preclinical
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
PMID 19406981·Am J Respir Crit Care Med·2009
4-observational
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
PMID 19520903·Am J Respir Crit Care Med·2009
4-observational
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
PMID 19620331·Antimicrob Agents Chemother·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4940 EASTERN AVE
BALTIMORE, MD 21224 - Phone
- (410) 550-0501
Quick Facts
- NPI
- 1477593150
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile